Skip to content
Wednesday, November 11, 2026
Update Modern 360

Patients Discontinuing Weight-Loss Medications Put On Pounds Far More Rapidly Compared to People Using Diet and Exercise

Image of medical syringe and weighing machine
Weight management often requires ongoing approaches.

A recent study indicates that people who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who halt traditional diet and exercise plans.

Published data in a prominent medical journal shows that while obese people frequently drop about a fifth of their body weight while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month once they quit.

"Users purchasing these medications should be informed of the potential of quick weight regain when the therapy is stopped," stated expert Dr. Susan Jebb.

That rate of regain means a return to original weight in about 18 months.

Comparing Treatments

The analysis, which reviewed dozens of studies involving thousands of patients, contrasted the results of these new drugs with other pills.

Scientists note that people who lose weight through lifestyle changes alone usually have a slower weight regain—approximately 100 grams monthly—post-intervention.

Explaining the Quick Regain

Doctors believe the mode of action of the jabs accounts for the accelerated rebound.

GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate hunger.

"Sustained high doses of GLP-1 levels several times higher than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Stopping of this GLP-1 'fix' results in appetite is no longer kept in check, making binge eating a significant risk."

A Chronic Issue?

Health authorities suggest the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Many experts say that, due to the likelihood of relapse, the therapy might need to be ongoing.

This perspective is supported by pharmaceutical companies, who say that the results "underscore the long-term character of excess weight," similar to managing diseases like hypertension.

User Experiences

Individuals who have discontinued the jabs report a powerful resurgence of appetite.

"It was like a trigger activating and you become extremely hungry," described a patient.

The struggle is compounded if patients have not developed permanent lifestyle or habit modifications during treatment.

Widespread Use

Survey data indicate that millions of people in the UK have used weight-loss jabs in the past year, with interest being substantial.

  • Adoption is greater among women compared to men.
  • The 40s and 50s demographic shows the highest level of interest.
  • A large proportion access the medications through private healthcare rather than the NHS.

In conclusion, researchers emphasize that while these medications are powerful tools for weight loss, they are not a standalone fix and long-term success relies on ongoing behavioural management.

By

Brandi Thomas

A tech enthusiast and digital strategist with over a decade of experience in analyzing emerging technologies and their impact on modern life.

Update Modern 360

Type to search articles.